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1. Introduction  
Down syndrome (DS), or trisomy 21, is a genetic alteration caused by the presence of an 
extra chromosome 21. In different parts of the world, the incidence of DS varies from 0.3 to 
3.4 per 1000 births, with a ratio of 1:1000 births being reported principally in America and 
Europe (Canfield et al., 2006; Hassold et al., 1996; Wahab et al., 2006; Webb et al., 2007). DS is 
associated with cardiovascular diseases; deficiencies of the digestive, immune, and 
endocrine systems; hematological problems; and also early onset of Alzheimer disease 
(Freeman et al., 2008; Holland et al., 2000; Linabery et al., 2008; Van Cleeve & Cohen, 2006; 
Wiseman et al., 2009). 
Compared to children without this syndrome, children with DS have ten- to twenty-fold 
higher risk of developing acute leukemia (AL) (Fong & Brodeur, 1987; Malinge et al., 2009; 
Ross et al., 2005a; Taub, 2001); it is estimated that approximately 1–2% will develop 
leukemia (Hasle et al., 2000; Malinge et al., 2009; Taub, 2001). Of those children with DS who 
develop leukemia, 60% is classified as having acute lymphoblastic leukemia (ALL) and 40%, 
with acute myeloblastic leukemia (AML). Of those with AML, the most common type is M7, 
or acute megakaryoblastic leukemia (AMKL), found in 62% of this group of children 
(Hitzler & Zipursky, 2005). Approximately 10% of children with DS are born with a 
transitory myeloproliferative syndrome (TMS) that, in some cases, spontaneously 
disappears during the first few months of life; nevertheless, approximately, 20% of these 
children irreversibly develop AML. Children with DS have up to 500-fold higher risk of 
developing AMKL during the first four years (Hasle et al., 2000, 2001; Malinge et al., 2009; 
Zipursky, 2003). 
Because the high incidence of AL in children with DS is strong evidence of the participation 
of chromosome 21 in the development of AL, investigation has been directed toward the 
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search for a gene, or genes, on chromosome 21 which may cause an interruption of cellular 
differentiation and mark the onset of AL. Research has been focused specifically on the 
study of the relation that exists between TMS and its developing into AMKL in patients with 
DS (Gamis & Hilden, 2002; Roy et al., 2009; Taub & Ravindranath, 2002; Zwaan et al., 2010). 
Study of this model has permitted the identification of the genes that provoke mutations 
that cooperate in the malignant transformation of hematopoietic precursor cells. One of 
these genes is GATA1 (Hitzler et al., 2003; Vyas & Roberts, 2006; Zwaan et al., 2010), which 
codes for a transcription factor of chromosome X which codes for the signaling of zinc which 
is essential for the differentiation of erythrocytes and magakaryocytes in the hematopoietic 
cell line. Mutation in this gene causes the production of the short protein, GATA1s, having 
an altered capacity of transactivation, thus contributing to the uncontrolled proliferation of 
immature megakaryocytes (Cantor, 2005; Hitzler et al., 2003; Wechsler et al., 2002). It has 
been found that mutation occurs in utero and, therefore, acts as an early pathological event, 
prior to the onset of TMS; however, in the absence of trisomy 21, such mutation is not 
sufficient for the induction of leukemia. Another transcription factor RUNX1, encoded by a 
gene on chromosome 21, plays a very important role in the development of AML (Hitzler & 
Zipursky, 2005; Izraeli et al., 2007). RUNX1 is essential for the differentiation of 
megakaryocyte progenitors and is responsible for the reduction of platelets (Migas et al., 
2011; Speck & Gilliland, 2002). The function of RUNX1 is commonly interrupted by 
chromosomal translocations that have been associated with different types of AL. These 
include the translocation t(8;21) that generates the fusion gene RUNX1/CBFA2T1 or 
AML1/ETO, which is associated with 40% of the AML type M2; the translocation t(12;21), 
called fusion gene ETV6/RUNX1 or TEL/AML1, which is associated with 20% of ALL of the 
pro-B-cell precursors; and the gene that codes for CBFǃ and that is the target of 
chromosomal aberrations such as inv(16) and t(16;16) in AML type M4 (Karrman et al., 2006; 
Zuna et al., 2011). Although it had been thought that GATA1 and RUNX1 were exclusive, it 
was later shown that RUNX1 cooperates with GATA1 during megakaryocytic 
differentiation, playing a very important role in predisposing a patient with DS to develop 
AMKL (Elagib et al., 2003). Nevertheless, in a recent study by the Children's Oncological 
Group (COG), it was found that children with DS had significantly fewer ETV6/RUNX1 
abnormalities than did children without DS (Maloney et al., 2010). Other genes that undergo 
mutations are Janus Kinase 2 (JAK2) and Janus Kinase 3 (JAK3) (Malinge et al., 2009); these 
genes are located on chromosome 9p24 and activate the encoding of tyrosine kinase, which 
has been reported in the majority of patients with myeloproliferative disorders. This type of 
mutation brings about a dysregulation of the activity of the kinase and a phosphorylation of 
tyrosine (Meydan et al., 1996; Mullighan et al., 2009). However, it has been shown that 
patients with DS who have this mutation have a better response to chemotherapeutic 
treatment. Other potential candidates include the transcription factors of the family of proto-
oncogenes, such as ETS, ERG, and GABPǂ, which have been shown to be expressed and to 
functionally participate in megakaryocytic differentiation (Wiseman et al., 2009). The 
dysregulation of the proto-oncogene EGR has been observed in different types of cancer; 
EGR is over-expressed in AML, just as the proto-oncogene ETS2 is over-expressed in AMKL; 
this dysregulation directly affects the cell cycle by regulating the expression of genes that 
require DNA synthesis and the degradation of the inhibitors of the cell cycle. It appears to a 
critical regulator of the development of lymphocytes in the precursors of B cells (Holterman 
et al., 2010; Sashida et al., 2010). 
From the foregoing and from other reports in the literature, the mechanisms that predispose 
children with DS to develop AL are augmented by chromosome fragility, alteration of DNA 
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repair mechanisms, immunological alterations, and the increase of viral replication 
(Robison, 1992; Xavier & Taub, 2010). If it is true that trisomy 21 can increase the 
proliferation of normal lymphoid progenitors, then for the children with DS (who already 
have a genetic susceptibility) to develop leukemia, this proliferation must be accompanied 
by additional events such as exposure of these children to environmental risks (Levanon et 
al., 2001; Rabson, 2010; Ross, 1999). Several environmental factors have been studied in 
children with DS: exposure in utero to X-rays; post-natal exposure to ionizing radiation, 
certain chemicals (such as pesticides and benzene), or to electromagnetic fields (EMF); habits 
of the parents, such as alcohol consumption and tobacco use before and during the 
pregnancy, or vitamin consumption; and viral infections of the mother during the 
pregnancy or of the child after birth. 
2. Environmental factors associated with development of AL in children with 
DS 
There have been relatively few studies concerning the association between exposure to 
environmental factors and the development of AL in children with DS; a brief description of 
the findings of these studies is germane to the current discussion. 
Linabery et al. (2006) and the COG carried out a case-control study to determine if there 
were an association between exposure to radiation (X-rays) and the development of AL in 
children with DS. Of the 158 children with DS and AL who were identified from the 
registration files of COG, 97 had ALL and 61 had AML); the controls, 173 healthy children 
with DS, were selected from the same primary-care hospitals or clinics where the cases were 
treated in a normal fashion before their being diagnosed with AL. Three periods of possible 
exposure to radiation were studied; these were prior to conception, in utero, and postnatal. 
Data for the variable of the study was obtained by means of a telephone interview with the 
parents. In this interview, the parents were asked about any episodes of exposure to 
radiation (X-rays) during these periods. The results showed that there was no association 
between exposure to radiation and the development of ALL and AML in children with DS. 
The limitations of this study are due to the manner in which the exposure was measured 
and to the fact that the type of radiation, the radiation dose, and the part of the body 
exposed were not taken into account. In addition, it is probable that there had been a bias in 
the identification of the controls: not all the primary-care physicians furnished a list of 
potential controls; therefore, the authors had to seek a care center different than the one that 
had treated the case. 
Data from these same groups of children were used in another case-control study conducted 
by the COG to determine if exposure of the mother to pesticides in the home was associated 
with the risk of AML or ALL in their children with DS. Positive associations with the 
development of ALL were found for exposure to pesticides in the home (odds ratio (OR): 
2.25; 95% confidence interval (CI): 1.13, 4.49); to a pesticide (OR: 2.18; 95% CI: 1.08, 4.39); and 
to a chemical (OR: 2.72; 95% CI: 1.17, 6.35). No statistically significant association for AML 
was found in children with DS. The notable limitation in this study is that a third of the 
mothers and physicians were unable to provide data for the potential controls, so that 
another physician was consulted (Alderton et al., 2006). 
Another case-control study concerned the relation between parental habits (smoking 
tobacco and alcoholism by the father) prior to the pregnancy or the passive exposure of the 
child to tobacco smoke and the development of leukemia by the child with DS. In this study, 
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the sample size was 27 children with DS who had leukemia (ALL = 22; AML = 5) and 58 
controls who were recruited from institutions of special education for children with DS. The 
parents of the case children and control children were interviewed concerning the frequency 
of their exposure to tobacco in the year prior to the pregnancy and during the pregnancy 
and concerning the passive exposure of the child to tobacco smoke prior to diagnosis (Mejía-
Aranguré et al., 2003). Risk of the child with DS to develop AL was associated with the 
father's having smoked during the year prior to the pregnancy (OR: 3.57; 95% CI: 0.82, 
20.27); with the father's having consumed alcohol in the year prior to the pregnancy (OR: 
3.10; 95% CI 1.12, 8.62; and with the child with DS having been passively exposed to tobacco 
smoke (OR: 3.39; 95% CI: 1.09, 10.48). Although the sample size was small, important 
associations were encountered. However, it is probable that there was a bias in the selection 
of the control group. 
Another of the factors that have generated numerous studies is the relation of the exposure 
of children to magnetic fields (MF) and the development of AL. This study was carried out 
with children with DS: 42 children had DS and ALL, with 124 healthy children with DS as 
controls. The controls were recruited from institutions providing special education to 
children with DS. The principal variable of exposure was measured in the home of the child 
by means of a gausometer, in addition to visual inspection of the wiring around the house. 
For each of the children, the parents were interviewed by health-care personnel at the 
attending health-care center. The data so obtained indicated that there was a positive 
association when there had been an exposure to MF >6.00 mG (OR: 3.7; 95% CI: 1.05, 13.1). It 
is interesting to note that, despite the few number of cases, the risk was found to be high, 
thus showing that, for children with a high susceptibility to environmental exposures that 
carry a risk, such factors become evident even though few individuals are studied. 
Nonetheless, it is probable that this study contains the same selection bias as the previous 
study (Mejía-Aranguré et al., 2007). 
Puumala et al. (2007) conducted a case-control study to determine whether the reproductive 
history of the mother or infertility treatment was associated with a risk for the children with 
DS to develop ALL or AML. As mentioned earlier in this section, of the 158 cases captured 
by COG, 97 were diagnosed with ALL and 61, with AML; the 173 controls were healthy 
children with DS. To measure the variable of exposure, a telephone interview was carried 
out, evaluating the reproductive history and infertility treatment. The results were null; only 
an association between AML in children with DS was reported when an infertility treatment 
had been performed one year prior to the pregnancy (OR: 2.22; 95% CI: 1.14, 4.33). The 
possible limitations to this study are that the controls were recruited from the same clinic 
from which the cases had been recruited; however, a list of potential controls was not 
always available. Also, there could have been a memory bias when measuring the principal 
variable. 
Ross et al. (2005b) studied the consumption of vitamins close to the time of conception and 
its association with the development of AL in children with DS. This case-control study 
utilized the same 158 children with DS and AL (97 cases with ALL; 61 with AML) that had 
been identified by COG and 173 healthy children with DS as controls. The mother of each 
child was interviewed by telephone to obtain information concerning the consumption of 
these supplements prior to the pregnancy and both before and after realizing that she was 
pregnant. A decrease in the risk of leukemia was observed when the vitamins had been 
taken as supplements during the periconception period (OR: 0.63; 95% CI: 0.39, 1.00). When 
stratified by type of leukemia, the risk of ALL was reduced (OR: 0.51; 95% CI: 0.30, 0.89); this 
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was not found for AML (OR: 0.92; 95% CI: 0.48, 1.76). Consumption of vitamins during the 
periconception period after the realization of the pregnancy was associated with an increase 
in the risk of leukemia (OR: 1.61; 95% CI: 1.00, 2.58), for both ALL and AML. It should be 
pointed out that there was a possible confusion bias due to the increased risk of consuming 
vitamins by the mother after becoming pregnant; therefore, an underlying biological process 
could confound the study. 
The role of infections in the etiology of leukemia and DS also has been under intensive study. 
By means of a case-control study using the same group of patients taken from the COG 
registry (the number of patients, recruitment of the controls, and measurement of the variable 
were given in more detail in foregoing paragraphs), the Children's Oncology Group (COG) 
evaluated the association between both the mother's state of health and episodes of infections 
during the pregnancy and the development of AL. The results obtained showed that the health 
problem most frequently encountered during pregnancy was vaginal bleeding, which had an 
associated reduction in the risk for AL for all the cases (OR: 0.57; 95% C: 0.33,0.99). The 
mother's having undergone amniocentesis was associated with an increase in the risk for AML 
(OR: 2.06; 95% CI: 0.90,4.69). One of the biases in this study is that of memory, due to the 
length of time between the pregnancy and the study interview (Ognjanovic et al., 2009). 
In a case-control study that used this same group of children (details of the COG study, 
including cases, controls, and interview are given in foregoing paragraphs), Canfield et al. 
(2004) studied whether early infections in children with DS, as well as infections that the 
mothers underwent during pregnancy, played a role development of AL. In this study, it 
was found that there was a negative association between the risk of AL and any infection 
during the first two years of life: OR: 0.55: 95% CI: 0.33,0.92 for combined AL; OR: 0.53; 95% 
CI: 0.29,0.97 for ALL; and OR: 0.59; 95% CI: 0.28,1.25 for AML. 
Similarly, Flores-Lujano et al. (2009) investigated whether either infections or breastfeeding 
was associated with risk of AL in children with DS. In this case-control study, the sample 
size was 57 children with DS and AL (45 ALL and 12 AML), with 218 healthy children with 
DS as controls. The controls were recruited from centers of special education for children 
with DS. Health-care personnel carried out the interviews in the health-care centers and in 
the special education institutions. In these interviews, questions specifically focused on 
infections and hospitalization in the first year of life and on breastfeeding. Although a 
statistically significant association was not found for these factors and general AL, 
hospitalization for an infection during the first year of life increased the risk (OR: 3.57; 95% 
CI: 1.59,8.05). Together with the foregoing results, this indicates that alteration of the 
immunological micro-environment could increase the risk for the development of AL in 
children with DS. A characteristic of these children is their having a higher frequency of 
infections than children without DS. This aspect should be investigated in greater depth. 
3. Infection and leukemia in children 
3.1 Infections and space-time clustering of children with childhood leukemia 
The theme of viral infections and childhood leukemia has been approached through cluster 
analysis. The findings are interpreted in both a time and space context. Due to studies of this 
type, possible evidence has been postulated that support the idea of an infectious etiology in 
childhood leukemia (Francis et al, 2011; McNally et al, 2009). Studies of this type describe 
geographical and historical units, not individuals or populations per se. Though the results 
of such studies make reference to individuals and populations, the interpretations given 
have to be placed on a time line or in a geographical territory. 
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Under the foregoing terms, a cluster consists of a group of persons, who group together, 
whether temporally, geographically, or both temporally and geographically. When found to 
cluster simultaneously both temporally and geographically, this phenomenon is known as 
space-time clustering. 
McNally and Eden (2004) commented that if infections are implicated in the etiology of 
childhood leukemia, then the geographic distribution of those children would demonstrate 
a space clustering within a determined time frame (McNally & Eden, 2004); that is to say, 
that they would form a space-time clustering. 
With the premise that a space-time clustering can show evidence of an infectious etiology 
for children with leukemia, we performed a revision of the publications that concern this 
theme by availing ourselves of the information retrieval system provided by Pub Med, 
PubMed is a free database maintained by the United States National Library of Medicine at 
the National Institutes of Health. We compared the number of cluster-analysis studies in 
general with that of studies that specifically dealt with space-time clustering. Then, we 
further refined the search to retrieve the space-time studies that concerned children with 
leukemia. Finally, we made a brief description of the type and number of the publications 
that had been done concerning space-time clustering and children with leukemia (Table 1; 
Fig. 1). 
 
Key word 
Number of 
publications 
Cluster analysis 59761 
Cluster analysis + Leukemia 1292 
Cluster analysis + Childhood + 
Leukemia 
168 
Space-time clustering 1801 
Space-time clustering + Leukemia 124 
Space-time clustering + Childhood + 
Leukemia 
61 
Table 1. Number of publications retrieved by iterative searches of PubMed database by 
using distinct key words. (Access date: 4 March 2011) 
The key words (cluster analysis, space-time clustering; leukemia; childhood) utilized in 
PubMed were chosen because they are medical subject headings (MeSH), a controlled 
vocabulary for indexing articles in PubMed. These predetermined terms are used in the 
PubMed database to avoid omission of some study related to the theme of the search. We 
did not select any other limitation to annotate the search. The quantity of publications 
(59,761) retrieved when the term "cluster analysis" was used as the sole search word shows 
that this type of study is used widely. However, it should be noted that this number 
includes not only studies of clustering, but also studies by clustering.  
When "space-time clustering" was used as the search term, the results were distinct: 1801 
publications were retrieved. Of the 124 space-time clusterings concerning leukemia, 
approximately one half (61) dealt with childhood leukemia. These publications started in 
1968 with a study, presented at a symposium, which was published in Nippon Ketsueki 
Gakkai Zasshi (Hirayama, 1968). In 1969, Glass & Mantel (1969) published a study 
www.intechopen.com
 
Infections and Acute Leukemia in Children with Down Syndrome   
 
85 
concerning children in Los Angeles, California, in which mortality data were used in an 
exceptional way. 
 
 
Fig. 1. Quantity of publications, retrieved by iterative searches of PubMed (see text), 
concerning both space-time clustering and childhood leukemia 
The annual publication rate of such studies increased slowly until reaching a maximum in 
1991; thereafter they started to decline. However, since the end of the last century, there 
appeared new peaks, notably in 1999, 2005, and 2009, thus showing a possibly renewed 
interest in performing this type of study.  
The reason that such studies are performed may be due to the fact that populations 
worldwide live within a demarked time and geographical area. Infections are processes that 
are also limited to a time, to a space, and to a population. These studies cannot demonstrate 
solid support for any relation, but their consistency can provide a very strong argument. 
The two principal hypotheses of the concept of the infectious etiology of childhood 
leukemia, those postulated by Greaves (1988) and by Kinlen (1988), have been consistently 
supported by these cluster analysis studies and their results inspire other researchers to 
continue studies on this possible relation.   
3.2 Viral theories of cancer and leukemia 
In the first half of the last century, the viral theory of cancer and leukemia was almost in 
disrepute. So much so, that there was great difficulty in obtaining funds or laboratory facilities 
for research projects dealing with the hypothetical virus origin of cancer (Gross, 1974). In 1951, 
it was demonstrated that a transmissible virus causes mouse leukemia (Gross, 1951a). In those 
experiments, when inoculated into newborn mice of a non-leukemic inbred strain, filtrates 
prepared from leukemic mouse tissues were found to induce leukemia or lymphosarcomas. 
Complicated genetic theories had been used to explain the phenomenon of the development of 
"spontaneous" leukemia in successive generations of mice of certain inbred lines, such as AK 
www.intechopen.com
  
Prenatal Diagnosis and Screening for Down Syndrome 
 
86
or C58. However, the correct explanation was provided by the demonstration that mouse 
leukemia virus is transmitted, in a latent form, from one generation to another directly through 
the embryos (Gross, 1951b), probably through the germinal cells (Ahmed, 2005). The activation 
of the virus may not occur during the lifespan of the carrier host and the host may remain in 
good health, even though it carries the virus and transmits it to its progeny. A variety of 
tumors and leukemias in several animal species were found to be caused by filterable viruses, 
transmissible by inoculation of newborn host. The mouse-leukemia virus induces leukemia 
not only in mice but also in rats; it can be transmitted from rat-to-rat filtrates (Gross, 1963). Cat 
leukemia was found to be caused by a virus transmissible by filtrates not only from cats but 
also from dogs (Jarrett et al., 1964; Rickard et al., 1973, as cited in Dutcher & Chieco-Bianchi, 
1973). It is still not understood why certain tumors and leukemias, such as mammary tumors 
in mice or leukemia in mice, cats, or chickens, contain virus particles and can be readily 
transmitted to other hosts by filtered extracts; similar tumors and lymphomas, which develop 
naturally in other species such as dogs, rats, and humans, do not seem to contain virus 
particles. This may be due to improper experimental methods; for example, no virus particles 
had been found in bovine lymphosarcoma until these leukemic cells were placed into short-
term tissue cultures (Gillet et al., 2007). 
In 1969, in an apparent attempt to elucidate the role of viruses in the etiology of cancer, Todaro 
and  Huebner (1972) proposed the "oncogene" theory, suggesting that most cells of vertebrates 
carry, as an essential part of their natural evolutionary inheritance, "oncogenic information" 
(the oncogene), and that cancer results from the destruction of the normal "repressor system" 
that keeps both the oncogenic and virogenic information in check in the normal adult cell. In 
other words, "endogenous virogenes" (genes for the production of type-C viruses) and 
oncogenes (the portion of the virogene responsible for transforming a normal cell into a tumor 
cell) were maintained in an unexpressed form by "repressors" in normal cells. Agents, such as 
radiation, chemical carcinogens, or the normal process of aging, could activate the genes and 
may transform cells by "switching on" the endogenous oncogenic information (Huebner & 
Todaro 1969; Todaro & Huebner, 1972). Gross (Gross, 1963; Jarrett, 1964; Rickard et al., 1973, as 
cited in Dutcher & Chieco-Bianchi, 1973) pointed out that there is a fundamental difference 
between the vertical theory and the oncogene theory (Gross, 1963). The concept of vertical 
transmission of oncogenic viruses assumes that, at some point, the oncogenic viruses entered 
the animal host from outside and, since that time, have been passed from one generation to the 
other as a latent infection (Jarrett, 1964), whereas the "oncogene" theory postulates that the 
genome responsible for producing the infectious virus is part of the inherited genetic material 
of all cells of normal vertebrates. Gross furthered commented that, in the former case, the 
oncogene theory would be very similar to the original concept of vertical transmission of latent 
oncogenic viruses, with only some significant changes in terminology and with the 
assumption that latent oncogenic viruses are present in almost all somatic cells of vertebrates. 
If the oncogene theory assumes that infectious viruses can be produced from normal 
endogenous components of healthy, normal not infected cells, then such a concept would be 
untenable, without returning to the old concept of spontaneous generation of infectious agents 
(Rickard et al., 1973, as cited in Dutcher & Chieco-Bianchi, 1973). 
3.2.1 Kinlen's hypothesis 
Infection has been causally linked to some leukemias in animals and in adult humans and 
has often been considered as a basis for childhood leukemia. If childhood leukemia does 
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have such an origin, the lack of an appreciable space-time clustering suggest that the 
infection is spread mainly by trivially infected subjects, rather than by children with 
leukemia. In 1990, Kinlen suggests that childhood leukemia represents a rare response to a 
much commoner, perhaps an unidentified mild or subclinical, infection, the transmission of 
which is facilitated when large number of people come together, particularly when they are 
from a variety of origins (Kinlen et al., 1990). This hypothesis was discussed in a study that 
showed a significant increase in childhood leukemia in a rural district in Scotland. This area, 
located at a distance from a conurbation and having no nuclear power installation in the 
vicinity, experienced a large influx of people during the 1950's (Kinlen, 1988) . Kinlen 
mentions that, when evaluating the findings, it is crucial to take into consideration the 
factors that are likely to increase the scale of contacts between susceptible people and the 
carriers of an unrecognized infection. Such factors, in the presence of that infection, may 
promote the development of leukemia and probably an epidemic of the infection itself, 
producing discernible long-term effects. Contact between those infected and susceptible 
individuals is the basis for the spread of any infection. That the total number of potential 
contacts is of great importance has been shown in occupational studies of infections such as 
influenza (Oxford et al., 2005) and tuberculosis (Hewitt &Stewart, 1951), as well as in the 
description of outbreaks of many other infections. New contacts between members of 
different communities must have occurred on an unusual scale both directly and indirectly 
as new towns rapidly grew in this area (Kinlen, 1988). Kinlen added that the greater the 
diversity in geographic origins among sizeable groups of residents, the more likely it is that 
appreciable differences in herd immunity will be found among different subgroups. The 
rate of progress of an epidemic is primarily regulated by the number of susceptible people 
and by the rate of contact between those infected and susceptible people (Fox et al.,1971). 
The best-known cluster of childhood leukemia is that in Niles, Illinois, USA, which consisted 
of eight cases during 1957–60, seven of whom were pupils of a single parish school. The 
population of Niles grew from 3587 in 1950 to 20 393 in 1960, with most of the increase 
occurring in 1955–60 and in the parish that later experienced the leukemia cluster (Heath & 
Hasterlik, 1990). The increased opportunity for new contacts, both in the crowed parish 
school (class size of 50) and in the adjoining church, could have favored both transmission 
of an infectious agent and repeated exposure to infected individuals. 
3.2.2 Greaves' hypothesis 
Greaves (1986) proposed that, at its peak incidence at about ages 3 and 4 years, ALL is due 
not to specific viruses, but to mutations that may delay exposure to various non-specific 
infective agents as well as to other immunological challenges (Greaves, 1986). Kinlen (1990) 
implied that, as this hypothesis is difficult to test epidemiologically, it would be problematic 
to distinguish definitively such effects from those of specific agents, as are observed in the 
majority of infection-based illnesses (Kinlen, 1990). 
Kinlen (1990) concluded that their findings provide support not only for infection being a 
basis for childhood leukemia (not only the lymphatic type), but also specifically for an 
infection being promoted by greater levels of social contact, particularly among people from 
communities that previously has been widely separated. In locales where an excess of 
childhood leukemia has been recorded, the dynamics of herd immunity in such 
communities, taken as a whole, must be given greater attention. 
Furthermore, Greaves and Chan suggest that much of the variation reported in the literature 
is a consequence of selective under-reporting and premature death in places where socio-
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economic conditions are poor (Den Otter et al., 1986). They also pointed out that the rate of 
lymphocyte proliferation in early childhood will be influenced by the pattern of exposure to 
micro-organisms, which will vary with social, environmental, and geographical factors. The 
idea of spontaneous mutations is not new. In one study, Den Otter et al. (1987) attempted to 
calculate both the incidence of the so-called "endogenous malignancy" and the number of 
mutations required for carcinogenesis by using measured mutant frequencies (Gross, 1951). 
Morris (1989) referred to the Den Otter study when he proposed an improved mathematical 
formula for application specifically to the incidence of lymphoid malignant (Morris, 1989). 
Morris concluded that his mathematical model showed that, if an increased mutation rate 
affects a subset of cell divisions, then the number of cell generations affected is more 
important than the absolute number of cell divisions affected. He is aware that the model he 
proposed fails to explain the age distribution of ALL without an additional assumption of a 
fallible mechanism that normally would eliminate malignant-clones. In this case, the 
activation of one growth-control gene by the loss of two regulatory genes would be enough 
for neoplasia. 
3.2.3 Alexander's hypothesis 
The Leukaemia Research Fund Data Collection Survey (DCS) is a specialist registry of 
leukemias and lymphomas, which collects high-quality incidence data for about half of 
England and Wales. The DCS published an atlas for 1984–88 (Alexander et al., 1991), in 
which the incidence of childhood ALL recorded by the registry was related both to aspects 
of community lifestyle from the 1981 census of England and Wales and to the Ordnance 
Survey digitized 1/625000 map data. The main findings were tested by applying them to the 
Yorkshire Region Children's Tumor Registry (YRCTR) for 1974–83. Although Yorkshire is in 
the DCS area, the two data sets are independent because the time periods do not overlap. 
Alexander considered these data and found that the association between ALL and radon 
persisted after adjustment for lifestyle factors (Cartwright et al, 1990). It was observed that 
higher rates of leukemias in children and young people had been reported in areas of higher 
socio-economic class and socio-economic status. These considerations led to the hypothesis 
that the incidence of childhood ALL was higher in communities that were isolated, were of 
higher socio-economic status, and had substantial numbers of commuting individuals. The 
relevant factors and classifications by each individually were selected in advance of the 
inspection of incidence data. The findings did not support any association between 
childhood ALL and commuting-to work distances. However, there was significant evidence 
that incidence increases, particularly for the childhood peak-age range, with distance from 
built-up areas. Further analysis of the DCS data showed that the highest rates of childhood 
ALL were found in those "middle-class" towns and villages which were farthest from urban 
conurbations. Initial confirmation was given by YRCTR data, with a similar two-fold 
difference in risk in both data sets. Alexander suggested that the interpretation of the 
findings and those of Kinlen (Kinlen,1988,1990) and of Cook-Mozaffari et al. (Cook-
Mozaffari et al.,1989) was that the lifestyle in isolated communities, i.e., those of higher 
economic status, is conducive to an unusual exposure to some specific infectious agent or to 
general infections. This exposure can, in turn, increase the risk of childhood leukemia. 
In contrast, Greaves model proposes that no specific agent is involved, but that the reduced 
exposure to antigenic challenge in infancy leads to greater proliferation of pre-malignant 
clones that can experience a second malignant change as a result of later infection (Greaves 
& Chan, 1986). Alexander mentioned that, if it is the timing of exposure to infections that is 
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relevant, then the results found would strongly support the first part of Greaves hypothesis, 
when it can be shown that the children in the isolated communities experience reduced 
antigenic challenge in infancy. Therefore, the earliest social grouping may provide an 
environment particularly conducive to the spread of infections (Davis, 1986) which, Greaves 
suggests, would facilitate the second malignant event. The authors conclude that their 
findings tend to favor Greaves model, but further investigations of these communities will 
be straightforward and have the potential to refine the infection-as-causal-agent models for 
the etiology of childhood ALL. Possible interpretations include germ-cell damage prior to 
conception (Fairlie, 2009; Gardner et al., 1990), synergism between viruses and radiation 
(Pinkel & Nefzger, 1959), and some unknown extra factor. 
3.3 Infection during the first year of life and childhood leukemia. Epidemiological 
evidence 
Epidemiological studies have been performed to determine whether an infection during the 
first year of life is a factor that influences the causality of childhood AL, and specifically ALL. 
Kinlen and Greaves (1988) proposed that infections may be involved in reducing the risk of 
developing AL. For that reason, epidemiological studies have evaluated the relation between 
early infections and childhood AL. The infections that have been evaluated include otitis 
media, common colds, respiratory tract infections, streptococcus-caused infections, influenza, 
asthma, gastrointestinal diseases, infections causing diarrhea or vomiting, and infections that 
may have been recurrent in an early stage or that may have required hospitalization, such as 
exanthema-like diseases typical of infancy. These studies have demonstrated that exposure to 
such infections permit the stimulation and maturation of the immunological system of the 
child, thus reducing the risk that, when challenged by a later infection, the child's immune 
system would respond in an aberrant manner, resulting in AL. Given that the lymphoid 
leukemic cells represent a clonal expansion of white cells, these act in the human body as the 
first line of defense against infectious agents, that normally are regulated by lymphocytes, 
monocytes, and neutrophils, which in turn neutralize and eliminate the pathogenic agent. 
Therefore, if there is a aberrant or abnormal response to an infection, it could occasion in the 
child an excessive proliferation of mutated cells as the immunological response to the late 
infection, or else it could fails to halt the proliferation of malignant cells (Chan et al., 2002; 
Dockerty et al., 1999; Greaves & Alexander, 1994; Greaves, 1988; Greaves, 2006; Jourdan-Da et 
al., 2004; Kinlen, 1988; McNally & Eden, 2004; Ma et al., 2005a; Ma et al., 2009; Neglia et al., 
2000; Perillat et al., 2002a; Rudant et al., 2010; Urayama et al., 2011; van Steensel et al., 1986). 
The majority of studies carried out to evaluate this association have been epidemiological 
designs of the case-control type. Such studies have shown that, when children had been 
exposed to common infections during the first year of life, there was a reduction in the risk 
of developing AL. However, not all the studies have shown this association; thus, early 
infection as a causal agent of childhood AL remains a controversial issue. Nevertheless, the 
importance of early infection during the first year of life, whether resulting in a reduction or 
an increase in the risk of developing AL, has not been discarded (Table 2)(Cardwell et al., 
2008; Chan et al., 2002; Dockerty et al., 1999; Jourdan-Da et al., 2004; McNally & Eden, 2004; 
McArthur et al., 2008; Ma et al., 2005a; Ma et al., 2009; Neglia et al., 2000; Perillat et al., 
2002b; Petridou et al., 2001; Roman et al., 2007; Rosenbaum et al., 2000; Rudant et al., 2010; 
Shüz et al., 1999; Urayama et al., 2011; van Steensel et al., 1986;). 
Some researchers have opted not only to evaluate the relation between early infections and 
AL by determining the involvement not only of common infections, but also of the  
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Author, 
Year 
(Country) 
Van Steensel et al., 
1986  
(The Netherlands) 
Schüz et al., 1999 
(Germany) 
Dockerty et al., 1999 
(New Zealand) 
Neglia et al., 2000  
(USA) 
Design of 
study 
Case-control study 
(1973–1980) 
Case-control 
study in two parts
(1980–1994) 
Case-control study 
(1991–1995) 
Case–control study 
(1 January 1989 and 
15 June 1993) 
Size of 
sample 
492 cases, 480 
controls; age: 0-14 
years 
1184 cases, 2588 
controls; age: 0-14 
years 
121 cases, 303 controls; 
age: 0-14 years 
1842 cases, 1986 
control; age: <15 
years of age 
Data 
collection 
Mailed 
questionnaire; 
addressed to 
diagnosis 
Telephone 
interviews of 
parents 
Mothers interviewed at 
home; standardized 
questionnaires and 
serological tests 
Structured 
interview 
Variables 
Breast feeding; birth 
order; family size; 
social class; number 
of rooms in 
household; 
infections; 
hospitalization or 
consultation for 
infections; primary 
infections (measles, 
chickenpox, mumps, 
or rubella); periods 
of fever 
First-born child; 
duration of 
breastfeeding; 
deficit in social 
contacts; routine 
immunizations; 
infections; 
tonsillectomy or 
appendectomy; 
allergy of the 
child; allergy of 
the mother 
Social class, marital 
status, ethnic group, 
educational level of 
parent; home 
ownership; length of 
gestation; age of mother 
at child's birth; weight 
of child at birth; 
exposure of mother to 
X-rays during the first 
trimester; exposure of 
child to X-rays or 
radiotherapy before 
onset of illness. Tobacco 
smoking by mother in 
first trimester or before 
pregnancy 
Interview of 
mother; gender; 
age; race; 
educational level of 
mother; 
educational level of 
father; family 
income; 
immunophenotype 
class. 
Odds ratio 
and 
relevant 
results 
Common colds RR: 
0.8, (95% IC: 0.6-1.0);
periods of fever RR: 
0.9;( 95% IC: 0.7-1.2);
primary infections 
RR: 0.8; (95% IC: 0.4-
2.0); these variables 
were adjusted by 
birth order, family 
size, social class, and 
residential space. 
Infectious diseases 
requiring 
hospitalization RR: 
0.6; (95% IC: 0.4-1.0).
Routine 
immunizations 
between 0-3 years 
of age OR: 3.2; 
(95% IC: 2.3-4.6); 
tonsillectomy or 
appendectomy (at 
least one) OR: 1.4; 
(95% IC: 1.1-1.9); 
child with allergy 
OR: 0.6; (95% IC: 
0.5-0.8). Having 
had tonsillectomy 
or appendectomy 
increased child's 
risk of developing 
leukemia, whereas 
allergies showed a 
protective effect. 
A positive relation was 
found between the 
infection caused by 
influenza during the 
first year of life and the 
risk for developing 
leukemia OR: 6.8; (95% 
CI 1.8-25.7). No other 
variable was related to 
acute leukemia. 
Neither attendance 
at, nor time 
remaining in day 
care was associated 
with the risk of 
developing 
leukemia. For 
children with 1–4 
episodes of ear 
infections or 
sustained 
infections, the 
association with 
development of 
acute leukemia was 
not statistically 
significant. 
Table 2. Summary of reviewed articles concerning the epidemiology of early infection and 
acute childhood leukemia 
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Author, 
Year 
(Country) 
Infante et al., 2000 
(Quebec, Canada) 
Rosenbaum 
et al., 2000 
(New York, USA) 
Perillat et. al., 2002b 
(France) 
Chan et al., 2002 
(Hong Kong) 
Design of 
study 
Case-control study 
(1989-1995 
Case-control study Case-control study 
A population based, 
case-control study 
(November 1994 and 
December 1997) 
Size of 
sample 
491 cases 
491 control 
age: 0-9 years 
 
255 cases, 
760 controls; 
age: 0-14 years; 
31 county region  
(cases); 
(1980-1991) 
280 incident cases; 
288 hospital controls 
116 cases, 788 
controls; 
Age: 2-14 years; the 
Hong Kong 
Paediatric 
Haematology and 
Oncology Study 
Group 
 
Data 
collection 
Structured 
questionnaire 
administered to 
mothers by telephone
Standarized 
questionnaires 
mailed to the 
parents 
 
Standarized face-to-face 
interviews of the mothers
Standarized, face-to 
face interviews 
Variables 
Educational level of 
mother; family 
income at the time of 
child's diagnosis; 
mother's age; father's 
age; tobacco smoking 
by mother; infections 
during pregnancy; 
child's birth order; 
attendance at day 
care or nursery; 
principal feeding 
method (breast or 
bottle); length of 
breastfeeding; 
history of recurrent 
infections of mother; 
use of antibiotics 
during pregnancy 
Sex; race; 
educational level 
of mother; birth 
order; feeding 
status at birth 
(breast, bottle); age 
at diagnosis; day 
care or preschool 
program; family 
outcome; maternal 
employment 
during the 
pregnancy. 
Diagnosed categories 
(acute leukaemia 
classification and 
immunophenotype); sex; 
age; ethnic origin; 
hospital where case 
capture; educational 
level of mother; 
occupation of mother at 
time interview, socio-
professional categories; 
place of residence; birth 
order; number of 
siblings; day care; age at 
start of day care; 
repeated infections 
before age 2 years; 
surgical operation for 
early ear-nose-throat 
infections before age 2 
years; breastfeeding. 
Medical history 
(infectious illnesses) 
in the first year of 
life; breastfeeding; 
day care/social 
contacts of index 
and siblings; own 
household 
environment; 
community 
environment. 
Odds ratio 
and 
relevant 
results 
Early attendance at 
daycare or at nursery 
and breastfeeding 
were protective 
factors against the 
development of acute 
leukemia OR: 0.49, 
Children who 
attended day care 
for >36 months, 
compared with 
those that did not, 
had a lower risk 
for developing 
An inverse association 
was found between the 
development of acute 
leukemia and attendance 
at day care OR: 0.6; (95% 
CI: 0.4-1.0), repeated (≥4 
per year) early common 
Child had rubella 
and/or fever during 
first year of life 
lowered the risk OR: 
0.33; (95% CI: 0.16-
0.68); change of 
residence during 
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(95% CI: 0.31-0.77) 
and OR: 0.68; (95% 
CI: 0.49-0.95), 
respectively. 
leukemia OR: 1.32, 
(95% CI: 0.70-2.52); 
attendance at day 
care for 1-18 
months OR: 1.74; 
(95% CI: 0.89-3.42) 
or for 19-36; OR: 
1.32; (95% CI: 0.64-
2.71). 
infections before the age 
of 2 years OR: 0.6 (95% 
CI: 0.4-1.0), and surgery 
for infection of nose, ear, 
or throat before age of 2 
years OR: 0.5 (95% CI: 
0.2-1.0). Statistically 
significant interaction 
was found between 
attendance at day care 
and repeated common 
infections. 
first year of life 
presented a lower 
risk of child's 
developing leukemia 
OR; 0.47; (95% 
CI:0.23-0.98), 
whereas with such 
change during 
second year, the risk 
increased, OR: 3.92; 
(95% CI: 1.47-10.46). 
Table 2. (cont'd) 
 
Author, 
Year 
(Country) 
Jourdan-Da 
et al. 2004 
(France) 
Rosenbaum P et 
al., 2005 
(New York, USA) 
Ma et al., 2005b 
(USA) 
Roman et al., 2007 
(United Kingdom) 
Design of 
study 
Case-control study 
(1995-1998) 
Population-based 
case-control study
(1980-1991) 
 
Population-based, 
case-control study 
(1991-1996) 
Size of 
sample 
473 cases, 
567 population-based 
controls 
255 cases, 
760 control; 
age: 0-14 years 
294 incident cases, 
376 controls; 
age: 0-14 years 
455 cases, 
1031 controls; 
age: 0-14 years 
Data 
collection 
Questionnaire Questionnaire 
Personal interview of 
parents 
Interview of parents 
Variables 
Gender; age at 
diagnosis; region of 
residence at 
diagnosis; socio-
professional 
categories; 
educational level of 
mother; educational 
level of father; birth 
weight; term of 
pregnancy; birth 
order; mother's age 
at birth; Down 
syndrome; 
breastfeeding; 
infections in the first 
year of life. 
Sex; race; birth 
year; mother's 
educational level; 
family income; 
maternal smoking; 
infant feeding at 
birth; birth order; 
attended day care 
before 25 months 
of age; year of 
diagnosis 
leukemia; age at 
diagnosis 
leukemia; 
allergies; history of 
allergies; common 
infections (colds, 
otitis media, 
influenza, croup, 
bronchiolitis, 
pneumonia, 
vomiting, 
diarrhoea)
Age; gender; 
household income; 
mother's educational 
level; mother's age at 
birth; birth weight; 
birth order; duration of 
breast feeding; day-
care attendance; 
infections during 
infancy 
Sex; age; diagnoses 
of infectious disease 
Odds ratio 
and 
relevant 
results 
Strong association 
found if child had 
gastrointestinal 
illnesses; attendance 
Results showed 
that infection late 
in the first year of 
child's life is 
Attendance at day care 
and infections during 
infancy is associated 
with a decrease in the 
Cases had more 
episodes of 
infection than did 
controls, which was 
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at day care lowered 
risk OR: 0.6; (95% CI: 
0.4-0.8); no 
association found for 
breastfeeding; birth 
order (4th or later) 
showed significant 
association with 
increased risk of 
acute lymphoblastic 
leukemia OR: 2.0; 
(95% CI: 1.1-3.7); 
child's prior episode 
of asthma was 
associated with a 
lower risk of 
developing acute 
lymphoblastic 
leukemia OR: 0.5; 
(95% CI: 0.3-0.9). 
associated with an 
increment in the 
risk of developing 
leukemia. 
risk of developing 
acute lymphoblastic 
leukemia within the 
white Hispanic 
population OR: 0.42; 
(95% IC: 0.18-0.99 and 
OR: 0.32; (95% IC: 0.14-
0.74), respectively; 
corresponding data for 
the Hispanic 
population, even for 
those living in the same 
area, did not agree. 
more notable in the 
neonatal period (≤1 
month): 18% of 
controls and 24% of 
cases with leukemia 
were diagnosed 
with an average of 
<1 infection OR: 1.4; 
(95% CI: 1.1-1.9; 
p<0.05). Cases with 
≥1 episodes of 
infection in the 
neonatal period 
tended to be 
diagnosed with 
acute lymphoblastic 
leukemia at a 
relatively young 
age. 
Table 2. (cont'd) 
 
Author, 
Year 
(Country) 
MacArthur, 
et al., 2008 
(British Columbia  
and Quebec,  
Canada) 
Cardwell et al., 
2008 
(United 
Kingdom) 
Urayama et al., 2010 
(USA) 
Rudant J et al., 2010 
(France) 
Design of 
study 
Population-based, 
case-control study 
(January 1,1990 and 
December 31,1994 
Nested  
case-control  
(cohort) study 
Case-control study 
(1995-1999) 
National registry-
based, case-control 
study ESCALE 
(2003-2004) 
Size of 
sample 
399 cases,  
399 controls; 
age: 0-14 years 
62 cases, 
2215 matched  
controls 
669 cases, 
977 controls; 
age: 1-14 years 
765 incident cases, 
1,681 controls. 
Data 
collection 
Standardized personal 
interviews in the home 
of child 
Data-based  
Questionnaire, 
interviews by 
telephone 
Variables 
Gender; age; mother’s 
age; father’s age; 
numbers of live births; 
annual household 
income; mother’s 
education; father’s 
education; ethnicity; 
vaccinations; illness 
and infections; 
breastfeeding; 
allergies; 
immunosuppressant 
medication for child; 
vitamins; antibiotics 
for child.
Sex; age; 
consultations; 
numbers of 
consultations; 
antibiotics 
prescriptions; 
common 
infections. 
Gender; mother’s age 
at child’s birth; 
mother’s educational 
level; annual 
household income; 
birth weight; breast-
fed; mother’s 
smoking; day-care 
attendance; history of 
common infections as 
child; ethnicity. 
Mother's 
educational level; 
parental 
professional 
category; place of 
residence at 
diagnosis; mother's 
age at child’s birth; 
number of children 
of age <15 years in 
the household; birth 
order; 
breastfeeding; 
duration of 
breastfeeding; early 
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common infections; 
surgical operation 
for ear-nose-throat 
infections; history 
of allergies; contact 
with animals; farm 
visit before age of 2 
years 
Odds ratio 
and 
relevant 
results 
No association found 
between early 
infections and acute 
leukemia; vitamin use 
was associated with a 
risk of developing 
acute leukemia OR; 
1.66; (95%CI: 1.18-
2.33); with use of 
immunosuppressors 
by child, there was a 
decrease in risk of 
leukemia OR: 0.37; 
(95% CI: 0.16-0.84); 
breastfeeding >6 
months had a 
protective effect 
against development 
of leukemia (p <0.05). 
One or more 
infections in the 
first year of life 
reduced the risk 
of leukemia OR: 
10.5; (95%CI: 0.69-
1.59;  
p = 0.83) and of 
acute 
lymphoblastic 
leukemia OR: 
1.05; (95%CI: 0.64-
1.74; p = 0.84). 
 
When variables were 
evaluated separately, 
both attendance at 
day care at 6 months 
of age and birth order 
reduced the risk of 
leukemia OR: 0.90; 
(95% CI: 0.82-1.00 and 
OR: 0.68; (95% CI: 
0.50-0.92), 
respectively) in a 
white non-Hispanic 
population, but not in 
a Hispanic 
population; however, 
if these children had 
ear infections, then 
the risk of developing 
acute leukemia was 
reduced OR: 0.45, 
(95%CI: 0.25-0.79). 
 
Negative 
associations were 
found for children 
with repeated 
common infections 
OR: 0.7; (95% CI: 
0.6-0.9); with a 
history of asthma or 
eczema OR: 0.7; 
(95% CI: 0.4-1.0) 
and OR: 0.7; (95% 
CI: 0.6-0.9), 
respectively; with 
attendance at day 
care before 1 year of 
age OR: 0.8; (95% 
CI: 0.6-1.1); and 
with prolonged 
breastfeeding OR: 
0.7; (95% CI: 0.5-
1.0). 
Table 2. (cont'd) 
 
Author, 
Year 
(Country) 
Urayama 
et al., 2011 
(USA) 
Design of 
study 
Observational studies 
(1993-2008) 
Size of 
sample 
14 case-control study 
Data 
collection 
Searches of Pub Med 
database and 
bibliographies of 
publications.  
Variables NA 
Odds 
ratio and 
relevant 
results 
Attendance at day care 
is associated with a 
reduced risk of acute 
lymphoblastic 
leukemia OR: 0.76; 
(95%CI: 0.67-0.87). 
Table 2. (cont'd) 
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environment in which the child may have been exposed to diverse infectious agents. Such is 
the case of attendance in a day care, taking this as a proxy variable to evaluate said 
infections. Given that in such environment, the child may be in very close contact to those 
with childhood diseases or other common diseases. This close contact would permit the 
child to become ill with greater or lesser ease; at the same time, the child's immune system 
would be stimulated, sooner or later, by such infections (Chan et al., 2002; Dockerty 1999; 
Jourdan-Da et al., 2004; Ma et al., 2005b; Ma et al., 2009; Perillat et al., 2002b; Rosenbaum et 
al., 2000; Urayama et al., 2010, Urayama et al., 2011). 
Urayama et al. performed two epidemiological studies in the USA, one was a case-control 
study (Urayama et al., 2010) and the other, a meta-analysis (Urayama et al., 2011). In the 
meta-analysis, the objective was to evaluate the association between the stay in day care 
during infancy and the risk of developing AL. Specifically, they evaluated whether early 
exposure to infection protected the child from AL, concluding that exposure of a child to 
common infections at an early age reduced the risk of developing AL (OR: 0.76; 95% CI: 
0.67–0.87) (Urayama et al., 2010; 2011). 
Studies carried out by Dockerty et al. (1999), Infante et al. (2000), Jourdan-Da et al. (2004), 
Ma et al. (2005b), and Perillat et al. (2002b) also supported these results. They showed that, if 
a child attends day care at an early age, the risk of developing leukemia is reduced. On the 
other hand, reports have been published that show no association between these infections 
or attendance in day care and the development of AL, or that show that rather than being a 
protective factor these variables are in fact risk factors for developing leukemia. Examples of 
such studies are those of Cardwell (2008), Dockerty (1999), and Neglia et al. (2000). 
3.4 Breastfeeding and acute leukemia. Epidemiological evidence 
Some epidemiological studies have evaluated breastfeeding as a possible protective factor. 
Given that it stimulates the immune response of the child, breast milk should be considered 
as the primary vaccine that the child receives during the first months of life, protecting the 
child from infections during this stage. Breast milk contains IgA antibodies against 
microorganisms and food antigens to which the mother has been exposed; in addition, the 
milk provides the child with immunoglobulins IgG and IgM, which stimulate phagocytosis 
and which prevent contact between microorganisms and epithelial cells of the host. The 
milk also contains B- and T-cell lymphocytes that are converted into lymphopoietic cells 
derived from the thymus and the spleen or equivalent tissue; these lymphocytes synthesize 
antibodies IgA, IgG, and IgM. By protecting the child from infections during the first year of 
life, breast milk can have an impact on the morbidity and mortality caused by diseases. 
Children fed exclusively with breast milk have fewer infections than do those who were 
never breastfed (Field, 2005; Macías et al., 2006; Parker, 2001; Reverón, 1995). 
These epidemiological findings are supported by several case-control studies which showed 
that breastfeeding plays an important role in reducing the risk for developing AL during 
infancy, as breastfeeding can influence the immune response to an infection, modulating the 
system's response to a challenge (Altinkaynak et al., 2006; Bener et al., 2001; Beral et al., 2001; 
Davis, 1998; Field, 2005; Guise et al., 2005; Infante et al., 2000; Ip et al., 2007; Kwan et al., 
2004; Perillat et al., 2002a; Shu et al., 1995, 1999; Stuebe, 2009).  
Meta-analyses of case-control studies have been performed in order to evaluate the role of 
breastfeeding. Guise et al. (2005) performed a systematic review of articles, published in 
different electronic databases, with the aim of evaluating the evidence concerning the effect 
of breastfeeding on the risk of developing childhood AL. These authors reviewed 111 
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citations, of which they identified 32 articles that had access to the complete article. They 
concluded that, in at least half the articles that they reviewed, the results support the idea 
that breastfeeding reduces the risk of developing AL. Kwan et al. (2004) carried out a meta-
analysis in order to quantify the findings concerning duration of breastfeeding and the risk 
of developing ALL and/or AML. They identified 14 case-control studies in which 
breastfeeding that lasted <6 months or >6 months was evaluated. Breastfeeding for >6 
months was found to reduce the risk of developing ALL (OR; 0.76; 95% CI: 0.68–0.84) and 
AML (OR: 0.85; 95% CI: 0.73–0.98); with breastfeeding for <6 months, this reduction was not 
lost. Ip et al. (2007) also performed a systematic review to evaluate this association between 
breastfeeding and AL. They evaluated case-control three studies, the results of which 
showed that breastfeeding for >6 months is associated with a reduction in the risk of 
developing ALL (OR: 0.80; 95% CI: 0.71–0.91). (Guise et. al., 2005; Kwan et al., 2004). 
3.5 Breastfeeding and acute leukemia in children with DS 
Very few studies have evaluated the effect of early infections and breastfeeding in children 
with DS. One such study was carried out by Canfield et al. (2004) in which they evaluated 
the relation between early infections and the development of AL, while also evaluating 
breastfeeding in children with DS. Children with AL diagnosed between January 1997 and 
October 2002 were recruited through the COG. As mentioned in section 2, the sample size 
was 158 children with both DS and leukemia and 173 healthy children with DS as controls. 
For the children with DS who had had infections during the first two years of life, the risk of 
developing AL was reduced (OR: 0.55; 95% IC: 0.33–0.92), as compared to the children who 
had been infection-free during that period (Canfield et al., 2004). 
In contrast, the results of a study carried out in Mexico City in children with DS did not 
support the findings of Canfield. In this study evaluating whether breastfeeding and 
infections during the first year of life demonstrated an association with the development of 
AL in children with DS, it was found that breastfeeding showed a protective effect, while 
early infection showed a factor risk of developing AL (OR: 0.84; 95% CI: 0.43-1.61 and OR: 
1.70; 95% CI: 0.82-3.52, respectively); however, these effects were not statistically significant. 
This study also evaluated hospitalization for these infections. The results showed that if a 
child >6 years of age presented an infection and in addition was hospitalized for said 
infection, the risk for developing AL was increased (OR: 3.57; 95% CI: 1.59–8.05); therefore, 
these results do not support the hypothesis, proposed by Greaves, that infections are a 
protective factor against the development of this disease (Flores et al., 2009).  
4. Conclusions 
The fact that our results agreed with reports in the literature that maternal breastfeeding 
during the first six months of life appeared to be a protective effect in the development of 
AL in children under six years of age should be underscored. The natural practice of 
breastfeeding does not put either the children or their mothers at risk and does not increase 
the expenses for the family or for society; therefore, independent of the strength of the 
mother-child bond that it fosters, breastfeeding should be encouraged as a measure that 
may lower the risk of children suffering AL during the first years of life (Guise et al, 2005). 
However, serious infections appeared to be an important risk factor in the development of 
AL in children over six years of age, especially for children from a low socio-economic 
background. 
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The role of infectious agents involved in these groups should be investigated if these are 
involved in the genesis of AL, above all, in those that occur in children older than six years. 
To date, the study of children with DS, a population with an elevated susceptibility for AL, 
has proved to be a very efficient design in the search for environmental factors associated 
with the development of AL. By using this design in several studies, we have identified 
associations important to the genesis of ALs, even when the sample size was not very large. 
The rationale to continue to use this design is that, if ALs result from the interaction of 
susceptibility to the disease and exposure to different environmental factors, then the search 
for the effect of these environmental factors in a non-susceptible population will always lead 
to erroneous results, because the population not susceptible to ALs will not develop the 
disease no matter how long they are exposed to such environmental factors. This design is 
an effective and efficient tool for use in studies elucidating the epidemiology of AL. 
However these results only apply to one population with like susceptibility for developing 
AL than children with DS. 
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